Label: ATROPINE SULFATE injection, solution
- NDC Code(s): 58005-354-04
- Packager: Sparhawk Laboratories, Inc
- Category: PRESCRIPTION ANIMAL DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved drug other
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Updated April 20, 2015
If you are a consumer or patient please visit this version.
INDICATIONS & USAGE
FOR ANIMAL USE ONLY
KEEP OUT OF REACH OF CHILDREN
CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
For use in Dogs and Cats as an antidote in the treatment of organophosphate insecticide poisoning; to reduce salivation, bronchial secretions or intestinal peristalsis associated with colic or diarrhea, and as a preanesthetic adjuvant.
DOSAGE AND ADMINISTRATION:
Dogs and Cats: Inject intravenously, intramuscularly, or subcutaneously, 1 mL for each 20 lbs of body weight as a preanesthetic adjuvant, or to reudce salivation, bronchial secretions, or intestinal peristalsis associated with colic or diarrhea.
As an antidote for parasympathomimetic drugs, inject 1 mL for each 5 lbs of body weight administered to effect and repeat as necessary. It is suggested that 1/4 of the dosage be injected intravenously and the remainder intramuscularly or subcutaneously.
- STORAGE AND HANDLING
- PRINCIPAL DISPLAY PANEL
INGREDIENTS AND APPEARANCE
atropine sulfate injection, solution
Product Information Product Type PRESCRIPTION ANIMAL DRUG Item Code (Source) NDC:58005-354 Route of Administration INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ATROPINE SULFATE (UNII: 03J5ZE7KA5) (ATROPINE - UNII:7C0697DR9I) ATROPINE SULFATE 0.54 mg in 1 mL Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:58005-354-04 100 mL in 1 VIAL Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 06/01/1997 Labeler - Sparhawk Laboratories, Inc (147979082)